Javascript must be enabled to continue!
Flow Cytometry for Evaluation of EGFR-mTOR Signal Way in the Growth Inhibitory Rate of Hela Cell Under Low Glucose and High Lactic Acid Environment
View through CrossRef
Objective: To discuss the effect of EGFR-mTOR signal way in the adaption of cervical carcinoma cell in low glucose and high lactic acid. Methods: Hela cells were cultured in four conditions: normal glucose (NG, glucose 10 mmol/L), low glucose (LG, glucose 3 mmol/L), high
lactic acid (HL, lactic acid 2.5 mmol/L) and low glucose and high lactic acid (LGHL, glucose 10 mmol/L, lactic acid 2.5 mmol/L). Growth inhibitory rate of Hela cell was determined by CCK-8; Flow cytometry (FCM) was performed to evaluate the cell cycle; Results: Compared with the rate
in NG, the rate in low glucose and high lactic acid was significantly increased (P < 0.01). Compared with the rate in NG, the rate of G1/G0 was increased in HL and in LGHL (P < 0.01, P < 0.01); the rate of G1/G0 in LG didn't have significant difference; the rates
of G2/M in HL and in LGHL were decreased, and the G2/M rate in LG was increased, but all of them had no statistically significant. The rates of S were decreased in HL, LG and LGHL (P < 0.05, no statistically significant, P < 0.05). The expression level of EGFR mRNA in Hela
was decreased and the level of mTOR mRNA was increased in HL (both had no statistically significant), when compared with the levels in NG. The expression level of EGFR mRNA was decreased (P < 0.05) and the level of mTOR mRNA was a little increased (no statistically significant) in
LG; while the EGFR and mTOR expression levels were increased in LGHL (P < 0.05). Conclusion: Low glucose and high lactic acid environment is conducive to Hela cell survival, and can promote the expression of EGFR and mTOR.
American Scientific Publishers
Title: Flow Cytometry for Evaluation of EGFR-mTOR Signal Way in the Growth Inhibitory Rate of Hela Cell Under Low Glucose and High Lactic Acid Environment
Description:
Objective: To discuss the effect of EGFR-mTOR signal way in the adaption of cervical carcinoma cell in low glucose and high lactic acid.
Methods: Hela cells were cultured in four conditions: normal glucose (NG, glucose 10 mmol/L), low glucose (LG, glucose 3 mmol/L), high
lactic acid (HL, lactic acid 2.
5 mmol/L) and low glucose and high lactic acid (LGHL, glucose 10 mmol/L, lactic acid 2.
5 mmol/L).
Growth inhibitory rate of Hela cell was determined by CCK-8; Flow cytometry (FCM) was performed to evaluate the cell cycle; Results: Compared with the rate
in NG, the rate in low glucose and high lactic acid was significantly increased (P < 0.
01).
Compared with the rate in NG, the rate of G1/G0 was increased in HL and in LGHL (P < 0.
01, P < 0.
01); the rate of G1/G0 in LG didn't have significant difference; the rates
of G2/M in HL and in LGHL were decreased, and the G2/M rate in LG was increased, but all of them had no statistically significant.
The rates of S were decreased in HL, LG and LGHL (P < 0.
05, no statistically significant, P < 0.
05).
The expression level of EGFR mRNA in Hela
was decreased and the level of mTOR mRNA was increased in HL (both had no statistically significant), when compared with the levels in NG.
The expression level of EGFR mRNA was decreased (P < 0.
05) and the level of mTOR mRNA was a little increased (no statistically significant) in
LG; while the EGFR and mTOR expression levels were increased in LGHL (P < 0.
05).
Conclusion: Low glucose and high lactic acid environment is conducive to Hela cell survival, and can promote the expression of EGFR and mTOR.
Related Results
Bioinformatics Analysis of Gefitinib or Rapamycin on Inhibiting the Survival of Hela in the Low Glucose and High Lactic Acid Environment
Bioinformatics Analysis of Gefitinib or Rapamycin on Inhibiting the Survival of Hela in the Low Glucose and High Lactic Acid Environment
Objective: To explore on the antitumor effect of gefitinib and rapamycin and possible mechanism in normal glucose and high lactic acid microenvironment. Methods: Hela cells are cul...
Experimental Evaluation of Lactic Acid for Matrix Acidizing of Carbonates
Experimental Evaluation of Lactic Acid for Matrix Acidizing of Carbonates
Summary
To improve the efficiency of standard hydrochloric acid (HCl) stimulation treatments, many alternative acid systems have been developed to mitigate corrosion...
Abstract 5463: Development of a novel antibody-maytansinoid conjugate, IMGN289, for the treatment of EGFR-expressing solid tumors.
Abstract 5463: Development of a novel antibody-maytansinoid conjugate, IMGN289, for the treatment of EGFR-expressing solid tumors.
Abstract
EGFR is an attractive target for the treatment of a variety of solid tumors because of its role as a driver oncogene and high level of expression. Four EGFR...
Role of mTOR in Hematopoiesis and Hematopoietic Stem Cell Regulation.
Role of mTOR in Hematopoiesis and Hematopoietic Stem Cell Regulation.
Abstract
Abstract 1490
Poster Board I-513
The mammalian target of rapamycin (mTOR) integrates nutrients, growth factors, and cellular e...
Plasma ctDNA biomarker study in patients with non-small cell lung cancer with EGFR exon 20 insertion mutation treated with sunvozertinib.
Plasma ctDNA biomarker study in patients with non-small cell lung cancer with EGFR exon 20 insertion mutation treated with sunvozertinib.
8563 Background: There are limited reports on biomarker studies of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutation (exon...
Complex Collision Tumors: A Systematic Review
Complex Collision Tumors: A Systematic Review
Abstract
Introduction: A collision tumor consists of two distinct neoplastic components located within the same organ, separated by stromal tissue, without histological intermixing...
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Pregnancy and Challenging Transient Anti-GAD65 Positivity: A Case Report with Literature Review
Abstract
Introduction
During pregnancy, women may develop blood glucose abnormalities like gestational diabetes mellitus (GDM) or, rarely, type 1 diabetes (T1D), which can lead to ...
Abstract B120: Preclinical assessment of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.
Abstract B120: Preclinical assessment of a mutant-selective covalent inhibitor of EGFR that overcomes T790M-mediated resistance in NSCLC.
Abstract
Non-small cell lung cancer (NSCLC) patients with activating epidermal growth factor receptor (EGFR) mutations initially respond well to first generation rev...

